Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABH001 for Stalled Chronic Wounds in Epidermolysis Bullosa
NCT01749306Phase 3Terminated
- Sponsor
- Takeda
- Start
- Dec 2012
- Primary completion
- Nov 2013
- Modality
- Stem Cell Therapies
- Countries
- 8
01
Overview
A Phase 3 trial of Foreskin fibroblast (neonatal) in epidermolysis bullosa (EB), sponsored by Takeda. Started Dec 2012; status: terminated.
02
Drugs
Foreskin fibroblast (neonatal)
03
Conditions
epidermolysis bullosa (EB)
Beyond the preview
Go deeper on NCT01749306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01749306.